Dr Reddy's Laboratories Ltd (FRA:RDDA)
€ 13.5 -0.1 (-0.74%) Market Cap: 11.25 Bil Enterprise Value: 10.55 Bil PE Ratio: 19.01 PB Ratio: 3.58 GF Score: 91/100

Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 09:30PM GMT
Release Date Price: €7.44
Neha Manpuria
JP Morgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I am Neha Manpuria, JPMorgan's India pharmaceutical and health care services analyst. Welcome to the JPMorgan Healthcare Conference Emerging Market Track. Thank you for being here. We'll start off the present -- India Track with Dr. Reddy's. We have Mr. Erez Israeli, the CEO of the company, presenting to us today. Over to you, sir.

Erez Israeli;s Laboratories Limited;CEO;Member of the Management Council
Dr. Reddy

'-&

So thank you, Neha. Thank you all. Thanks for all the people for coming. We know that we have the after lunch slot. It's not always easy. So we appreciate all the people that made the effort and came to see our presentations. We are competing against lunch and against a beautiful view outside, and we'll do our best to share with you our story and hope that you like it as well.

And before we start, also another wish, happy New Year for all of you and your families wherever you are.

So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot